clodronic acid has been researched along with Hyperparathyroidism, Primary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Accadia, M; Capozza, M; Chinellato, I; Di Lorgi, N; Di Mauro, A; Guarnieri, V; Laforgia, N; Mattioli, G; Traggiai, C | 1 |
Kuo, SW; Lee, IT; Pei, D; Sheu, WH; Tu, ST | 1 |
2 other study(ies) available for clodronic acid and Hyperparathyroidism, Primary
Article | Year |
---|---|
Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
Topics: Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Clodronic Acid; Diphosphonates; Female; Fluid Therapy; Furosemide; Genes, Recessive; Homozygote; Humans; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing | 2018 |
Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hyperparathyroidism, Primary; Hypocalcemia; Male; Middle Aged; Pamidronate; Parathyroidectomy; Preoperative Care; Retrospective Studies; Syndrome | 2006 |